Integrating AI in Postural Rehabilitation for Parkinson's Disease
Launched by IRCCS NATIONAL NEUROLOGICAL INSTITUTE "C. MONDINO" FOUNDATION · May 29, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of artificial intelligence (AI) to help improve posture in people with Parkinson's disease who have specific postural challenges, such as Pisa Syndrome or camptocormia. These conditions can cause significant difficulties, including leaning to one side or bending forward, which can lead to pain and balance issues. The researchers want to see if using an AI system that provides real-time feedback can help patients maintain better posture and improve their overall mobility and quality of life after they finish their initial rehabilitation in the hospital.
To be eligible for this study, participants need to be over 18 years old and have a diagnosis of Parkinson's disease. They should also be experiencing noticeable trunk postures, like bending forward or to the side. The study is currently looking for people who score above a certain level on a mental assessment test, ensuring they have the capacity to participate fully. If you join the trial, you'll be using a personalized exercise program at home, guided by AI, to help support your recovery and independence. This innovative approach aims to provide more effective and lasting benefits for those dealing with challenging postural issues related to Parkinson's disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age above 18 years
- • Diagnosis of Parkinson's disease according to MDS criteria
- • Hoehn and Yahr stage ≤ III
- • Clinical diagnosis of camptocormia (presence of an anterior axial trunk flexion of at least 30°), or of Pisa Syndrome (presence of a lateral trunk flexion of at least 10°) at the time of enrollment (T0)
- • Mini-Mental State Examination (MMSE) score \> 23
- Exclusion Criteria:
- • Atypical parkinsonian syndromes
- • History of spinal surgery
- • Previous vertebral trauma
- • Current or past spinal tumors or infections
- • Idiopathic scoliosis
- • Ankylosing spondylitis
- • Spinal canal stenosis
- • Other neurological conditions
- • Severe dyskinesias
About Irccs National Neurological Institute "C. Mondino" Foundation
The IRCCS National Neurological Institute "C. Mondino" Foundation is a prominent research institution in Italy dedicated to advancing the field of neurology through innovative clinical trials and scientific research. As a recognized IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), the foundation focuses on the diagnosis, treatment, and rehabilitation of neurological disorders, fostering collaboration among healthcare professionals, researchers, and academic institutions. Committed to translating cutting-edge research into clinical practice, the foundation aims to enhance patient care and improve outcomes for individuals affected by neurological diseases. Its rigorous approach to clinical trials ensures the highest standards of scientific integrity and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pavullo Nel Frignano, Pavia, Italy
Patients applied
Trial Officials
Luca Martinis
Principal Investigator
IRCCS Mondino Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported